A comprehensive report analyzing the global Imaging Contract Research Organization (CRO) market, covering definitions, service types, imaging modalities, applications, end-users, and regional market breakdowns. The study also includes import/export trends, demand-supply dynamics, gross margins, supply chains, and distribution channels.

 

📈 Market Size & Growth

  • Valued at USD 5.6 billion in 2024, projected to reach USD 11.1 billion by 2034, at a 7.2% CAGR
  • Other sources estimate USD 5.37 billion in 2024, rising to USD 8.19 billion by 2030, with a 7.23% CAGR
  • BIS Research reports growth from USD 4.50 billion in 2020 to USD 9.60 billion by 2031, at 7.25% CAGR
  • Imaging CRO services alone were valued at around USD 5.4 billion in 2024, expected to hit USD 9.5 billion by 2032, with 7.3% CAGR

Get a sample of the report @ https://www.emergenresearch.com/request-sample/3910

 

🔑 Key Growth Drivers

  • Rising prevalence of chronic diseases (oncology, neurology, cardiovascular) increases imaging-driven trials
  • Surge in clinical trials and R&D—especially in biotech/pharma—drives demand for outsourced imaging protocols .
  • Advancements in imaging tech (MRI, CT, PET) and AI-based image analytics enhance service value

 

⚠️ Challenges & Restraints

  • High cost of advanced imaging technologies and infrastructure limits smaller CROs
  • Regulatory and privacy constraints, along with data management complexities, remain key bottlenecks .
  • Market pressure due to both well-established global CROs and emerging local players

 

🧩 Market Segmentation

Segment

Subcategories

Services

Image Collection & Quality Control, Imaging Acquisition & Protocol Development, Digital Image Conversion, Application Design, Support & Maintenance, Others

Imaging Modality

MRI, CT, PET, Fluoroscopy, Mammography, Ultrasound, Nuclear Imaging, X‑ray, Others

Application

Oncology, Neurology, Cardiovascular, Ophthalmology, Gastroenterology, Gynecology, Orthopedics, Others

End-User

Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Academic/Research Institutes, Diagnostic Centers, Hospitals, Others

Region

North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

 

🌍 Regional Insights

  • North America leads (~45%–50% share) thanks to high trial volume, pharma presence, and infrastructure
  • Europe holds a solid share (~20–25%), with biotech hubs and CRO hubs in the U.K., Germany, and France
  • Asia-Pacific is the fastest-growing region (~25%), driven by increased outsourcing in China, India, and Southeast Asia
  • Latin America and MEA hold smaller shares (~5% each), while ramping up trials in emerging countries .

To know more about the report, click here @ https://www.emergenresearch.com/industry-report/imaging-cro-market

🏢 Competitive Landscape

Notable players profiled include:

  • Parexel, ICON plc, IXICO, WorldCare Clinical, Radiant Sage, Labcorp Drug Development, WuXi AppTec, Imaging Endpoints, Medpace, Biomedical Systems, Bioclinica
  • Perceptive (formerly Calyx + Invicro) rebranded in October 2024, emphasizing imaging and eClinical capabilities

 

📊 Analytical Framework

  • Porter’s Five Forces and SWOT analysis across services, modality, end-users, and regions.
  • Trend analysis: AI-driven imaging analytics, protocol automation, cloud-based data management, personalization of trials, and image biomarker development

 

📅 Report Scope & Methodology

  • Historical period: 2018–2023
  • Forecast period: 2024–2034 (varies by source)
  • Metrics: Revenue in USD million/billion; CAGR
  • Coverage: Market definitions, growth drivers and restraints, segmentation, regional profiles, competitive landscape, strategic frameworks, and customization options

 

✅ Key Benefits of Buying This Report

  • Multiple forecast scenarios with validated market sizing
  • Detailed service, modality, application, and end-user breakdowns
  • Regional hotspot identification with growth dynamics
  • Vendor profiling with strategic and tech partnerships
  • Analytical tools: Porter’s, SWOT, trend maps
  • Customizable chapters (e.g., Asia-Pacific surge, AI-powered imaging, startup profiles vs. large CROs)

Request customization on the report @ https://www.emergenresearch.com/request-for-customization/3910      

Thank you for reading our report. To know more about the customization of the report, please get in touch with us, and our team will ensure the report is suited to your requirements.

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

14671 110 Avenue, Surrey, British Columbia, V3R2A9

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services